These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4959184)

  • 21. Virulence factors from Aeromonas species.
    Abbey SD; Etang BB
    Microbios; 1988; 56(227):71-7. PubMed ID: 2468071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.
    Liu PV; Hsieh H
    J Infect Dis; 1973 Oct; 128(4):520-6. PubMed ID: 4200593
    [No Abstract]   [Full Text] [Related]  

  • 23. Contribution to knowledge of factors participating in virulence of Listeria monocytogenes. I. Isolation and properties of the biologically active complex E.
    Patocka F; Mára M
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(4):457-68. PubMed ID: 4207401
    [No Abstract]   [Full Text] [Related]  

  • 24. Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor.
    Marquart ME; Dajcs JJ; Caballero AR; Thibodeaux BA; O'Callaghan RJ
    Med Microbiol Immunol; 2005 Jan; 194(1-2):39-45. PubMed ID: 14628143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
    Homma JY
    Jpn J Exp Med; 1980 Jun; 50(3):149-65. PubMed ID: 6776324
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study of the pathogenicity of melanin-forming strains of Pseudomonas aeruginosa].
    Barshteĭn IuA; Tydel'skaia IL; Rozhavin MA
    Mikrobiol Zh (1978); 1983; 45(2):44-8. PubMed ID: 6191185
    [No Abstract]   [Full Text] [Related]  

  • 27. [A method for in vitro studies on the degradation of human plasma proteins by bacterial proteases using Pseudomonas aeruginosa as an example].
    Müller HE
    Zentralbl Bakteriol Orig; 1971; 216(1):79-87. PubMed ID: 4994621
    [No Abstract]   [Full Text] [Related]  

  • 28. Medium for the accumulation of extracellular hemolysin and protease by Aeromonas hydrophila.
    Riddle LM; Graham TE; Amborski RL
    Infect Immun; 1981 Sep; 33(3):728-33. PubMed ID: 7026444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biofilm-forming ability and infection potential of Pseudomonas aeruginosa strains isolated from animals and humans.
    Milivojevic D; Šumonja N; Medic S; Pavic A; Moric I; Vasiljevic B; Senerovic L; Nikodinovic-Runic J
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29684116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity.
    Thibodeaux BA; Caballero AR; Dajcs JJ; Marquart ME; Engel LS; O'Callaghan RJ
    Ocul Immunol Inflamm; 2005; 13(2-3):169-82. PubMed ID: 16019676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenicity of Pseudomonas aeruginosa].
    Rozhavin MA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Mar; (3):106-12. PubMed ID: 3133914
    [No Abstract]   [Full Text] [Related]  

  • 32. [Virulence factors of Pseudomonas aeruginosa].
    Vaca Pacheco S; Cervantes-Vega C
    Rev Latinoam Microbiol; 1988; 30(2):87-90. PubMed ID: 3146123
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of induction of virulence factor expression by activated charcoal in Listeria monocytogenes.
    Ermolaeva S; Belyi Y; Tartakovskii I
    FEMS Microbiol Lett; 1999 May; 174(1):137-41. PubMed ID: 10234832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on a protease (elastase) from Pseudomonas aeruginosa, I: formation and purification of the protease (author's transl)].
    Scharmann W; Balke E
    Hoppe Seylers Z Physiol Chem; 1974 Apr; 355(4):443-50. PubMed ID: 4215731
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of hemolysin in extracellular products of Pseudomonas cepacia.
    Nakazawa T; Yamada Y; Ishibashi M
    J Clin Microbiol; 1987 Feb; 25(2):195-8. PubMed ID: 3818916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytotoxic activity of Pseudomonas aeruginosa with regard to lecithinase, lipase, proteinase, hemolysine, and surface activity (author's transl)].
    Botzenhart K; Ebel EA
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):387-97. PubMed ID: 4150074
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa.
    Berk RS; Brown D; Coutinho I; Meyers D
    Infect Immun; 1987 Jul; 55(7):1728-30. PubMed ID: 3110070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heat-stable hemolysin of Pseudomonas aeruginosa].
    Fujita K
    Hokkaido Igaku Zasshi; 1987 May; 62(3):392-401. PubMed ID: 3111962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of Pseudomonas aeruginosa-haemolysin by electrophoresis.
    Výmola F; Lochmann O; Buda J; Jedlicková Z; Pillich J
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(1):23-7. PubMed ID: 4995066
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of extracellular products of Pseudomonas aeruginosa in the pathogenesis of infection; an experimental study employing intraperitoneal diffusion chambers.
    Al-Ssum RM; Harris DM; Underwood JC
    Br J Exp Pathol; 1980 Dec; 61(6):551-9. PubMed ID: 6779848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.